Company profile STRO
After 39 days of this quarter the interest is at 118.0. Based on that we can calculate that during remaining 52 days it will total up to 275.0. Sutro Biopharma expected interest is significantly higher compared to previous quarter (+85.8%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 50 | 256 412.0% QoQ | 203 -20.7% QoQ | 175 -13.8% QoQ |
| 2020 | 83 66.0% YoY -52.6% QoQ | 93 -63.7% YoY 12.0% QoQ | 166 -18.2% YoY 78.5% QoQ | 188 7.4% YoY 13.3% QoQ |
| 2021 | 71 -14.5% YoY -62.2% QoQ | 97 4.3% YoY 36.6% QoQ | 159 -4.2% YoY 63.9% QoQ | 179 -4.8% YoY 12.6% QoQ |
| 2022 | 273 284.5% YoY 52.5% QoQ | 235 142.3% YoY -13.9% QoQ | 163 2.5% YoY -30.6% QoQ | 219 22.3% YoY 34.4% QoQ |
| 2023 | 267 -2.2% YoY 21.9% QoQ | 302 28.5% YoY 13.1% QoQ | 177 8.6% YoY -41.4% QoQ | 148 -32.4% YoY -16.4% QoQ |
| 2024 | 118 -55.8% YoY -20.3% QoQ | - | - | - |
The average 5 years interest of Sutro Biopharma was 13.88 per week. The last year interest of Sutro Biopharma compared to the last 5 years has changed by 21.11%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 22.25%.
After 39 days of this quarter the interest is at 45.0. Based on that we can calculate that during remaining 52 days it will total up to 105.0. Sutro Biopharma stock expected interest is significantly lower compared to same quarter last year (-55.1%) but higher than previous quarter (+356.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 31 | 67 116.1% QoQ | 39 -41.8% QoQ | 23 -41.0% QoQ |
| 2020 | 75 141.9% YoY 226.1% QoQ | 57 -14.9% YoY -24.0% QoQ | 82 110.3% YoY 43.9% QoQ | 218 847.8% YoY 165.9% QoQ |
| 2021 | 244 225.3% YoY 11.9% QoQ | 125 119.3% YoY -48.8% QoQ | 177 115.9% YoY 41.6% QoQ | 99 -54.6% YoY -44.1% QoQ |
| 2022 | 61 -75.0% YoY -38.4% QoQ | 128 2.4% YoY 109.8% QoQ | 76 -57.1% YoY -40.6% QoQ | 86 -13.1% YoY 13.2% QoQ |
| 2023 | 234 283.6% YoY 172.1% QoQ | 144 12.5% YoY -38.5% QoQ | 87 14.5% YoY -39.6% QoQ | 23 -73.3% YoY -73.6% QoQ |
| 2024 | 45 -80.8% YoY 95.7% QoQ | - | - | - |
The average 5 years interest of Sutro Biopharma stock was 8.13 per week. The last year interest of Sutro Biopharma stock compared to the last 5 years has changed by 5.04%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 177.27%.
There is not enough data for Sutro Biopharma CD74 to provide analysis
There is not enough data for Sutro Biopharma CD74 to provide correlation calculation
There is not enough data for Sutro Biopharma CD74 to provide analysis
There is not enough data for Sutro Biopharma ADC to provide analysis
There is not enough data for Sutro Biopharma ADC to provide correlation calculation
There is not enough data for Sutro Biopharma ADC to provide analysis
There is not enough data for Sutro Biopharma ovarian cancer to provide analysis
There is not enough data for Sutro Biopharma ovarian cancer to provide correlation calculation
There is not enough data for Sutro Biopharma ovarian cancer to provide analysis
There is not enough data for Sutro Biopharma endometrial cancer to provide analysis
There is not enough data for Sutro Biopharma endometrial cancer to provide correlation calculation
There is not enough data for Sutro Biopharma endometrial cancer to provide analysis
There is not enough data for Sutro Biopharma ROR1 to provide analysis
There is not enough data for Sutro Biopharma ROR1 to provide correlation calculation
There is not enough data for Sutro Biopharma ROR1 to provide analysis
There is not enough data for Sutro Biopharma solid tumors to provide analysis
There is not enough data for Sutro Biopharma solid tumors to provide correlation calculation
There is not enough data for Sutro Biopharma solid tumors to provide analysis
There is not enough data for Sutro Biopharma collaboration to provide analysis
There is not enough data for Sutro Biopharma collaboration to provide correlation calculation
There is not enough data for Sutro Biopharma collaboration to provide analysis
There is not enough data for Sutro Biopharma headquarters to provide analysis
There is not enough data for Sutro Biopharma headquarters to provide correlation calculation
There is not enough data for Sutro Biopharma headquarters to provide analysis